Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Safety & Candidacy Multi-peptide therapy requires thorough medical evaluation to ensure safe and appropriate use
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
5-Amino-1MQ is supplied in a lyophilized (freeze-dried) form to support stability during transportation and storage
We firmly believe that your health should seamlessly integrate with your lifestyle
The MHRA regulates all injectable B12 products in the UK, ensuring quality and safety standards
